Q320 - The bright ray of sunshine companies had hoped for after dismal results in Q220 While Q220 is dow...
Orthopedics market stages a third-quarter rally while navigating a new norm. As the US healthcare system...
Strong interest in joint preservation amid COVID-19 pandemic During the month of October, the Internatio...
The Regenerative Medicine market for orthopedic and sports medicine applications is rapidly advancing as...
Heavy-weight contender COVID-19 landed some brutal blows to revenue in Q220, but companies look for bett...
Companies came out of the gate strong in Q120, but COVID-19’s one-two punch on elective procedures and c...
The orthobiologics market continues to ramp up studies and new product development as surgeries impacted...
A well-oiled engine, the Soft Tissue Fixation train was prepped for a good start to 2020, then COVID-19 ...
The mid-March madness of COVID-19 results in final missed shots for many companies. For sports fans, Mar...
Coming through Q120 bruised and expecting much harder punches before the calm, companies ride the COVID-...